Cobimetinib (GDC-0973) is a potent MEK1/MEK2 inhibitor. It blocks the MAPK signaling pathway by decreasing ERK phosphorylation and inducing PARP cleavage, effectively inhibiting tumor cell proliferation and promoting apoptosis.
Cobimetinib (GDC-0973) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Cobimetinib (GDC-0973) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Cobimetinib (GDC-0973) Mechanism of Action: MEK Inhibition in Melanoma Cell Research
- Cobimetinib (GDC-0973) Clinical Trials
- Cobimetinib (GDC-0973): Selectivity & Specificity
- Cobimetinib (GDC-0973) Working Concentration | Cell Culture | Treatment
- Cobimetinib (GDC-0973) Solubility in DMSO
- Cobimetinib (GDC-0973) Stock Solution
- Cobimetinib (GDC-0973) Storage
- Cobimetinib (GDC-0973) Stability
- Cobimetinib (GDC-0973) Combination Database
- Cobimetinib (GDC-0973) Molecular Weight
- Cobimetinib (GDC-0973) SMILES
- Cobimetinib (GDC-0973) CAS Number
- Cobimetinib (GDC-0973) Chemical Structure (2D and 3D)
- Cobimetinib (GDC-0973) Sigma (AMBH2D6FB248)? Try a better option.
- Cobimetinib (GDC-0973) MedChemExpress (HY-13064)? Try a better option.
- Cobimetinib (GDC-0973) Cayman (19563)? Try a better option.
- Cobimetinib (GDC-0973) APExBIO (A3321)? Try a better option.
- Cobimetinib (GDC-0973) SDS｜MSDS